Profund Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Sell |
28,676
-6,981
| -20% | -$121K | 0.02% | 465 |
|
|
2025
Q1 | $780K | Sell |
35,657
-8,662
| -20% | -$189K | 0.03% | 352 |
|
|
2024
Q4 | $1.41M | Buy |
44,319
+5,705
| +15% | +$182K | 0.05% | 241 |
|
|
2024
Q3 | $1.11M | Sell |
38,614
-4,354
| -10% | -$126K | 0.04% | 297 |
|
|
2024
Q2 | $1.65M | Buy |
42,968
+20,435
| +91% | +$784K | 0.06% | 207 |
|
|
2024
Q1 | $1.32M | Sell |
22,533
-25
| -0.1% | -$1.47K | 0.05% | 278 |
|
|
2023
Q4 | $1.35M | Sell |
22,558
-12,595
| -36% | -$754K | 0.06% | 267 |
|
|
2023
Q3 | $1.34M | Buy |
35,153
+18,766
| +115% | +$714K | 0.07% | 223 |
|
|
2023
Q2 | $1.49M | Sell |
16,387
-5,307
| -24% | -$483K | 0.08% | 206 |
|
|
2023
Q1 | $1.43M | Buy |
21,694
+8,972
| +71% | +$592K | 0.09% | 193 |
|
|
2022
Q4 | $658K | Buy |
12,722
+315
| +3% | +$16.3K | 0.04% | 353 |
|
|
2022
Q3 | $847K | Buy |
+12,407
| New | +$847K | 0.06% | 271 |
|